400 related articles for article (PubMed ID: 21720501)
81. Nanoparticles made of fluorescence-labelled Poly(L-lactide-co-glycolide): preparation, stability, and biocompatibility.
Weiss B; Schaefer UF; Zapp J; Lamprecht A; Stallmach A; Lehr CM
J Nanosci Nanotechnol; 2006; 6(9-10):3048-56. PubMed ID: 17048517
[TBL] [Abstract][Full Text] [Related]
82. Enabling anticancer therapeutics by nanoparticle carriers: the delivery of Paclitaxel.
Liu Y; Zhang B; Yan B
Int J Mol Sci; 2011; 12(7):4395-413. PubMed ID: 21845085
[TBL] [Abstract][Full Text] [Related]
83. One-step fabrication of polymeric Janus nanoparticles for drug delivery.
Xie H; She ZG; Wang S; Sharma G; Smith JW
Langmuir; 2012 Mar; 28(9):4459-63. PubMed ID: 22251479
[TBL] [Abstract][Full Text] [Related]
84. Functionalized nanoparticles provide early cardioprotection after acute myocardial infarction.
Chang MY; Yang YJ; Chang CH; Tang AC; Liao WY; Cheng FY; Yeh CS; Lai JJ; Stayton PS; Hsieh PC
J Control Release; 2013 Sep; 170(2):287-94. PubMed ID: 23665256
[TBL] [Abstract][Full Text] [Related]
85. Externally controlled triggered-release of drug from PLGA micro and nanoparticles.
Hua X; Tan S; Bandara HM; Fu Y; Liu S; Smyth HD
PLoS One; 2014; 9(12):e114271. PubMed ID: 25479357
[TBL] [Abstract][Full Text] [Related]
86. Marked augmentation of PLGA nanoparticle-induced metabolically beneficial impact of γ-oryzanol on fuel dyshomeostasis in genetically obese-diabetic ob/ob mice.
Kozuka C; Shimizu-Okabe C; Takayama C; Nakano K; Morinaga H; Kinjo A; Fukuda K; Kamei A; Yasuoka A; Kondo T; Abe K; Egashira K; Masuzaki H
Drug Deliv; 2017 Nov; 24(1):558-568. PubMed ID: 28181829
[TBL] [Abstract][Full Text] [Related]
87. Brain drug delivery and neurodegenerative diseases: Polymeric PLGA-based nanoparticles as a forefront platform.
Pinto M; Silva V; Barreiro S; Silva R; Remião F; Borges F; Fernandes C
Ageing Res Rev; 2022 Aug; 79():101658. PubMed ID: 35660114
[TBL] [Abstract][Full Text] [Related]
88. Exploiting the tumor phenotype using biodegradable submicron carriers of chemotherapeutic drugs.
Geary SM; Salem AK
Crit Rev Oncog; 2014; 19(3-4):269-80. PubMed ID: 25271435
[TBL] [Abstract][Full Text] [Related]
89. Following the concentration of polymeric nanoparticles during nebulization.
Beck-Broichsitter M; Knuedeler MC; Schmehl T; Seeger W
Pharm Res; 2013 Jan; 30(1):16-24. PubMed ID: 22806406
[TBL] [Abstract][Full Text] [Related]
90. Recent Advances in Nanoencapsulation Systems Using PLGA of Bioactive Phenolics for Protection against Chronic Diseases.
Abdul Rahim R; Jayusman PA; Muhammad N; Ahmad F; Mokhtar N; Naina Mohamed I; Mohamed N; Shuid AN
Int J Environ Res Public Health; 2019 Dec; 16(24):. PubMed ID: 31817699
[TBL] [Abstract][Full Text] [Related]
91. Pairing-Enhanced Regioselectivity: Synthesis of Alternating Poly(lactic-
Lu Y; Coates GW
J Am Chem Soc; 2023 Oct; 145(41):22425-22432. PubMed ID: 37793193
[TBL] [Abstract][Full Text] [Related]
92. A short appraisal of polylactic-co-glycolic acid based polymer nanotechnology for colon cancer: recent advances and literature evidences.
Vashishat A; Singh A; Kurmi BD; Gupta GD; Singh D
Ther Deliv; 2023 Jul; 14(7):459-472. PubMed ID: 37559461
[TBL] [Abstract][Full Text] [Related]
93. Polylactic-co-glycolic acid-based nanoparticles modified with peptides and other linkers cross the blood-brain barrier for targeted drug delivery.
Na Y; Zhang N; Zhong X; Gu J; Yan C; Yin S; Lei X; Zhao J; Geng F
Nanomedicine (Lond); 2023 Jan; 18(2):125-143. PubMed ID: 36916394
[TBL] [Abstract][Full Text] [Related]
94. Interaction of gentamicin and gentamicin-AOT with poly-(lactide-co-glycolate) in a drug delivery system - density functional theory calculations and molecular dynamics simulation.
Duran S; Anwar J; Moin ST
Biophys Chem; 2023 Mar; 294():106958. PubMed ID: 36682087
[TBL] [Abstract][Full Text] [Related]
95. The High Potency of Polymeric Nanoparticles in the Drug Delivery System for Hypertension Treatment: A Systematic Review.
Mohammadipour F; Kiani A; Amin A
Curr Hypertens Rev; 2022; 18(1):54-63. PubMed ID: 34547998
[TBL] [Abstract][Full Text] [Related]
96. Polymeric delivery of proteins and plasmid DNA for tissue engineering and gene therapy.
Richardson TP; Murphy WL; Mooney DJ
Crit Rev Eukaryot Gene Expr; 2001; 11(1-3):47-58. PubMed ID: 11693965
[TBL] [Abstract][Full Text] [Related]
97. Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals.
Wang S; Su R; Nie S; Sun M; Zhang J; Wu D; Moustaid-Moussa N
J Nutr Biochem; 2014 Apr; 25(4):363-76. PubMed ID: 24406273
[TBL] [Abstract][Full Text] [Related]
98. Advanced drug delivery systems of curcumin for cancer chemoprevention.
Bansal SS; Goel M; Aqil F; Vadhanam MV; Gupta RC
Cancer Prev Res (Phila); 2011 Aug; 4(8):1158-71. PubMed ID: 21546540
[TBL] [Abstract][Full Text] [Related]
99. Molybdenum-Iodine Cluster Loaded Polymeric Nanoparticles Allowing a Coupled Therapeutic Action with Low Side Toxicity for Treatment of Ovarian Cancer.
Verger A; Dollo G; Martinais S; Molard Y; Cordier S; Amela-Cortes M; Brandhonneur N
J Pharm Sci; 2022 Dec; 111(12):3377-3383. PubMed ID: 36126760
[TBL] [Abstract][Full Text] [Related]
100. Advanced application of nanotechnology in active constituents of Traditional Chinese Medicines.
Qiu C; Zhang JZ; Wu B; Xu CC; Pang HH; Tu QC; Lu YQ; Guo QY; Xia F; Wang JG
J Nanobiotechnology; 2023 Nov; 21(1):456. PubMed ID: 38017573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
